ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
TRex Bio, Inc.
10.32
+0.5950
6.12%
盘后:
10.32
0.0000
0.00%
19:30 EST
成交量:
9.32万
成交额:
94.52万
市值:
2.97亿
市盈率:
-5.74
高:
11.00
开:
9.83
低:
9.55
收:
9.72
52周最高:
16.56
52周最低:
9.06
股本:
2,878.87万
流通股本:
833.33万
量比:
0.51
换手率:
1.12%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.7980
每股收益(LYR):
-33.2025
净资产收益率:
--
总资产收益率:
--
市净率:
-2.45
市盈率(LYR):
-0.31
数据加载中...
总览
公司
新闻资讯
公告
别只盯着 Anthropic:生物科技公司正悄然主导 IPO 市场
老虎资讯综合
·
10/25
美股异动 | Trex Bio(TRXB.US)登陆美股市场 开盘后跌超1.3%
智通财经
·
10/10
礼来背书也难享溢价,TRex Bio (TRXB.US)发行价落至 14 美元区间下限
智通财经
·
10/09
专注于自身免疫性疾病和炎症性疾病的早期生物技术公司TRex Bio Inc.在美国首次公开募股(IPO)中筹资1.167
格隆汇
·
10/09
TRex Bio(TRXB.US)IPO定价14-16美元/股、拟募资1.25亿美元 礼来有意认购1300万美元
智通财经
·
10/06
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/TRXB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRXB\",,,,,undefined,":{"symbol":"TRXB","market":"US","secType":"STK","nameCN":"TRex Bio, Inc.","latestPrice":10.315,"timestamp":1795208400000,"preClose":9.72,"halted":0,"volume":93189,"hourTrading":{"tag":"盘后","latestPrice":10.315,"preClose":10.315,"latestTime":"19:30 EST","volume":316,"amount":3275.51,"timestamp":1795221006283,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.061213991769547206,"floatShares":8333300,"shares":28788654,"eps":-1.798,"marketStatus":"休市中","change":0.595,"latestTime":"11-20 16:00:00 EST","open":9.83,"high":11,"low":9.55,"amount":945157.5974969999,"amplitude":0.149177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.798,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":7,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":9.72,"postHourTrading":{"tag":"盘后","latestPrice":10.315,"preClose":10.315,"latestTime":"19:30 EST","volume":316,"amount":3275.51,"timestamp":1795221006283,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5131168595701525},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRXB\",,,,,undefined,":{"symbol":"TRXB","floatShares":8333300,"roa":"--","roe":"--","lyrEps":-33.202517,"volumeRatio":0.5131168595701525,"shares":28788654,"dividePrice":0,"high":11,"amplitude":0.149177,"preClose":9.72,"low":9.55,"week52Low":9.06,"pbRate":"-2.45","week52High":16.5608,"institutionHeld":0,"latestPrice":10.315,"eps":-1.798,"divideRate":0,"volume":93189,"delay":0,"ttmEps":-1.798,"open":9.83,"prevYearClose":14,"prevWeekClose":13.67,"prevMonthClose":13.74,"prevQuarterClose":14,"fiveDayClose":13.67,"twentyDayClose":13.81,"sixtyDayClose":14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRXB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRXB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1793854800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRXB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRXB","date":"2026-11-20","current":-5.73693,"percent":0.967742,"low":-8.994887,"twenty":-8.259047,"median":-7.970631,"eighty":-7.634628,"high":-5.527733,"avg":-7.812127,"sd":0.818556,"marketCap":265454969},"quantilePoints":[{"date":"2026-10-09","current":-8.124414,"twenty":-8.588667,"median":-8.414572,"eighty":-8.240477,"marketCap":376907832},{"date":"2026-10-16","current":-8.130218,"twenty":-8.202177,"median":-8.130218,"eighty":-7.938713,"marketCap":377177051},{"date":"2026-10-23","current":-8.014154,"twenty":-8.681517,"median":-8.179544,"eighty":-8.036206,"marketCap":371792654},{"date":"2026-10-30","current":-7.973532,"twenty":-8.546884,"median":-8.130218,"eighty":-7.979335,"marketCap":369908115},{"date":"2026-11-06","current":-7.694981,"twenty":-8.378592,"median":-8.031564,"eighty":-7.869075,"marketCap":356985560},{"date":"2026-11-13","current":-8.182446,"twenty":-8.353059,"median":-8.014154,"eighty":-7.849345,"marketCap":379600030},{"date":"2026-11-20","current":-5.721999,"twenty":-8.259047,"median":-7.970631,"eighty":-7.634628,"marketCap":265454969}],"updateTime":1795379934205},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRXB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157759837","title":"别只盯着 Anthropic:生物科技公司正悄然主导 IPO 市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1157759837","media":"老虎资讯综合","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157759837?lang=zh_cn&edition=fundamental","pubTime":"2026-10-25 11:17","pubTimestamp":1792898274,"startTime":"0","endTime":"0","summary":"City Therapeutics 于 10 月 16 日上市首日上涨近 30%,尽管此时整体市场表现疲弱。史密斯表示,许多公司更倾向于暂时观望,因为大多数拟上市企业都在等待当前市场波动结束、美国中期选举过去,以及 Anthropic 完成 IPO 之后再采取行动。《华尔街日报》报道称,一份 Anthropic IPO 申报文件草案显示,该公司在 2026 年上半年亏损超过 800 亿美元。不过,就目前而言,生物科技投资者似乎并没有受到 IPO 市场低迷的影响。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYCA","IPO002","CTY","IAM","RTSN","ANT","TRXB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2674286532","title":"美股异动 | Trex Bio(TRXB.US)登陆美股市场 开盘后跌超1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674286532","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674286532?lang=zh_cn&edition=fundamental","pubTime":"2026-10-10 00:11","pubTimestamp":1791562298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TRXB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674734836","title":"礼来背书也难享溢价,TRex Bio (TRXB.US)发行价落至 14 美元区间下限","url":"https://stock-news.laohu8.com/highlight/detail?id=2674734836","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674734836?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 14:55","pubTimestamp":1791528950,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注于自身免疫与炎症疾病的早期生物技术公司 TRex Bio Inc. 通过 IPO 募资 1.167 亿美元,发行价定在其推介区间的下限。此前提交的文件显示,这家生物技术公司此前给出的发行区间为每股 14 至 16 美元。按 IPO 发行价计算,总部位于旧金山的 TRex 市值为 3.84 亿美元,该数字基于文件中列出的流通股数量。此前文件显示,礼来已表示有意在此次 IPO 中认购股份,但不打算使其持股比例超过 19.9%。总量火热,回报分化TRex 有望延续美国医疗板块上市的火热之年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TRXB","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674240880","title":"专注于自身免疫性疾病和炎症性疾病的早期生物技术公司TRex Bio Inc.在美国首次公开募股(IPO)中筹资1.167","url":"https://stock-news.laohu8.com/highlight/detail?id=2674240880","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674240880?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 12:13","pubTimestamp":1791519187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BCSM","IPO","REDS","ACSG","KCE","SPCK","LQPE","HELX","IPOS","BK4127","QQQS","FRHC","WDNA","PEVC","TRXB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673526030","title":"TRex Bio(TRXB.US)IPO定价14-16美元/股、拟募资1.25亿美元 礼来有意认购1300万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673526030","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673526030?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 17:23","pubTimestamp":1791278612,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注于研发自身免疫和炎症性疾病药物的生物技术公司TRex Bio周一公布了其首次公开募股条款。该公司计划以每股14至16美元的价格发行830万股股票,筹集1.25亿美元。礼来计划在此次发行中认购价值1300万美元的股票。按发行价区间的中点计算,TRex Bio完全稀释后市值将达到4.53亿美元。其主要候选药物TRB-061是一种TNFR2激动剂,目前正处于治疗中重度特应性皮炎的1b期临床试验阶段,预计将于2027年中期公布初步数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TRXB","IPOS","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}